Amphastar Pharmaceuticals, Inc.
AMPH
$23.08
-$0.10-0.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -8.80% | -0.98% | |||
| Total Other Revenue | -- | -119.00% | |||
| Total Revenue | -8.58% | -2.45% | |||
| Cost of Revenue | -14.62% | 11.88% | |||
| Gross Profit | -1.61% | -15.00% | |||
| SG&A Expenses | 19.26% | -1.91% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.76% | 5.38% | |||
| Operating Income | -17.39% | -20.87% | |||
| Income Before Tax | -29.80% | -7.80% | |||
| Income Tax Expenses | -7.02% | -17.31% | |||
| Earnings from Continuing Operations | -33.40% | -6.10% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -33.40% | -6.10% | |||
| EBIT | -17.39% | -20.87% | |||
| EBITDA | -13.11% | -16.85% | |||
| EPS Basic | -32.93% | -4.83% | |||
| Normalized Basic EPS | -29.30% | -6.56% | |||
| EPS Diluted | -31.03% | -5.19% | |||
| Normalized Diluted EPS | -27.81% | -6.80% | |||
| Average Basic Shares Outstanding | -0.70% | -1.33% | |||
| Average Diluted Shares Outstanding | -2.77% | -1.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||